PART 2U.K.Amendment of Part 1 (General)

Amendment of regulation 4 (special provision for pharmacies etc)U.K.

[F16.  In regulation 4—

(a)in paragraph (4)(d)—

(i)in paragraph (i) insert “UK” before “marketing authorisation”;

(ii)after paragraph (i) insert—

(ia)the EU marketing authorisation,;

(b)in paragraph (6) for “269 (offences relating to packaging and package leaflets: other persons)” substitute “269 (offences relating to packaging and package leaflets in Great Britain: other persons), 269A (offences relating to packaging and package leaflets in Northern Ireland: other persons)”.]

Textual Amendments

F1Reg. 6 substituted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 3

Commencement Information

I1Reg. 6 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1